Thrombolytic Articles & Analysis: Older
3 news found
Over 99% of patients were treated in a single session and avoided the use of thrombolytics. “With 500 patients across 43 centers, CLOUT is the largest prospective data set ever reported evaluating interventional treatment of DVT,” said Dr. ...
PEERLESS commenced earlier this year and compares FlowTriever to catheter-directed thrombolytics in pulmonary embolism. “Anticoagulation is still the predominant therapy used in the management of DVT and in some studies has been associated with post-thrombotic syndrome (PTS) in up to 50% of patients,” said Dr. ...
Truvic’s innovative technology has been designed to redefine peripheral vascular thrombus management by enabling single-session thrombus removal without the use of thrombolytics. The program to explore novel therapies for peripheral vascular disease began as an independent development program inside of Imperative Care in 2019, and in February of 2020 Truvic was formed and ...